To investigate the influence of the anti-CTHRC1 antibody in vivo, two human pancreatic-cancer-bearing mouse models were established (subcutaneous BxPC-3, Figure 7A; and orthotopic CFPAC-1, Figure 7E). The gene discussed is CTHRC1; the disease is pancreatic neoplasm.